European Commission Approves Mirvetuximab Soravtansine for …
1 hour ago · “The approval of [mirvetuximab soravtansine] by the European Commission provides a much-needed clinically meaningful option for patients who receive the heartbreaking news …
AbbVie’s Elahere wins European approval for certain ovarian cancers
7 hours ago · The European Commission (EC) has granted marketing authorisation to AbbVie’s Elahere (mirvetuximab soravtansine) for the treatment of folate receptor-alpha (FRα) platinum …
UI is crafting a new drug to treat ovarian cancer - Radio Iowa
5 days ago · University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. ... Subscribe to get our latest news and information …
First clinical trial of “memory like” natural killer cells in ovarian ...
3 days ago · Epithelial ovarian cancer is the fifth leading cause of cancer-related mortality in women with most patients presenting with advanced disease at the time of diagnosis. The 5 …
Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer
Apr 24, 2024 · Platinum-resistant ovarian cancer has proven difficult to treat, but with the Food and Drug Administration’s recent full approval of mirvetuximab soravtansine-gynx (Elahere), …
Ovarian cancer - Latest research and news | Nature
3 days ago · Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women over 50.
Ovarian Cancer News - ScienceDaily
Oct 2, 2024 · Information about ovarian cancer symptoms and treatments. Explore the latest medical research on ovarian cysts and ovarian cancer including including stages of the …
A Game-Changer for Ovarian Cancer | Johns Hopkins Medicine
By Marc Shapiro on 06/06/2024. Ovarian cancer is a notoriously difficult group of diseases to diagnose and treat. There is no effective screening method — most people have widely …
Oxford researchers secure funding for world's first ovarian cancer ...
Oct 4, 2024 · Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Scientists at the University of Oxford are …
Preclinical Study Explores Approved Drug for Ovarian Cancer
Jul 29, 2024 · An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell …